Cancer cells frequently exhibit mitochondrial dysfunction, which can further influence metabolic reprogramming. Mutations in mitochondrial DNA or alterations in mitochondrial enzymes can disrupt oxidative phosphorylation, forcing cells to rely more on glycolysis. However, mitochondria remain essential for biosynthetic and signaling functions, highlighting their complex role in cancer metabolism.
